News

eHealth says surging 2027 health costs are pushing smaller employers toward ICHRAs, potentially expanding individual coverage demand.

SNDR, NESR and CNC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 18th, 2026.

Avnet, Centene, Signet and Lifetime Brands stand out as value plays as Fed tightening keeps focus on cash flow and discounted valuations.

Centene's diversified market presence, cash generation and recent share gains give it an edge over Oscar Health as ACA insurers target long-term growth.

THC, NESR and CNC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 16th, 2026.

CNC's and ADM's strong 2026 guidance, estimate revisions and attractive valuations offer fresh reasons to watch these non-AI stocks.

UnitedHealth (UNH) has spent the past year repairing margins rather than chasing growth. The shares rebounded well ahead of any actual margin recovery: up about 38% over the past six months, though down about 6% over the past three, and still behind the S&P 500 over the past twelve months, 12.2% for the stock against 18.6% for the index. What argues for owning them now shows up in cash running ahead of reported profit.

BP, NESR and CNC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 14th, 2026.

Elevance Health (ELV) has returned more than 40% over the past six months, though it is down 6.5% over the past three while the S&P 500 gained 3.4%. The next leg will not come from selling more insurance. It will come from keeping more of the premium it already collects.

The S&P 500 Index ($SPX ) (SPY ) is down -0.54% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.96%. E-mini S&P futures (ESU26 ) are down -0.50%, and September E-mini Nasdaq futures (NQU26...

Centene has outpaced the healthcare sector, and analysts remain moderately optimistic about the stock’s outlook.

CNC, ATI and SANM made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 10, 2026.

Humana has outperformed the broader Dow Jones index over the past year. Moreover, Wall Street analysts remain moderately optimistic about its prospects.

CNC, NESR and ATI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 8, 2026.

SMCI, ADM, ALL, CNC and AVT are five undervalued stocks with strong estimate revisions and growth prospects that could offer more upside in 2026.

Here is how Adicet Bio, Inc. (ACET) and Centene (CNC) have performed compared to their sector so far this year.

CNC, VLO, and MNDY it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 3rd, 2026.

Oscar Health's membership jumps 46% to 2.96 million, but seasonal enrollment and medical utilization keep profitability in focus.

CNC's 117% rally now has support from improving margins, firmer pricing and higher earnings expectations, while valuation remains below key peers.

CNC, VLO, and LCUT it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 2nd, 2026.

CNC, VLO, and MNDY it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 31, 2026.

COCO, DAR, CNC, EXC and AMRX offer a defensive appeal as consumer confidence hits a 7-month low amid inflation and labor market concerns.

CNC, ENS and VLO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 27th, 2026.

CNC, ENS and VLO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 25th, 2026.

CNC, ENS and VLO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 21st, 2026.

CNC, ATI and MNDY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 18, 2026

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Top-ranked stocks CNC, THC, FTNT, U and GS are likely to beat on the bottom line in their upcoming releases.

Centene stock has surged over the past year, yet the current checks still suggest it leans on the cheap side, so investors are weighing how much of the recent optimism is already reflected in the price. Centene has returned 145.2% over the past year, which puts a spotlight on whether the recent share price strength is outpacing the underlying fundamentals. Raised expectations for future revenue and earnings, together with a plan to redeem part of its debt, can support the case for improved...

BioMarin, Invesco, Centene, HPE and Gibraltar Industries stand out as undervalued stocks with low price-to-book ratios.